Literature DB >> 16648272

Phase I oncology trials: why the therapeutic misconception will not go away.

W Glannon.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16648272      PMCID： PMC2579408          DOI： 10.1136/jme.2005.015685

Source DB:  PubMed          Journal:  J Med Ethics        ISSN： 0306-6800            Impact factor:   2.903


× No keyword cloud information.
  14 in total

Review 1.  Money for research participation: does in jeopardize informed consent?

Authors:  C Grady
Journal:  Am J Bioeth       Date:  2001       Impact factor: 11.229

2.  Phase I cancer trials. A collusion of misunderstanding.

Authors:  M Miller
Journal:  Hastings Cent Rep       Date:  2000 Jul-Aug       Impact factor: 2.683

Review 3.  Defining and describing benefit appropriately in clinical trials.

Authors:  N M King
Journal:  J Law Med Ethics       Date:  2000       Impact factor: 1.718

4.  Clarifying the ethics of clinical research: a path toward avoiding the therapeutic misconception.

Authors:  Paul S Appelbaum
Journal:  Am J Bioeth       Date:  2002       Impact factor: 11.229

5.  A critique of clinical equipoise. Therapeutic misconception in the ethics of clinical trials.

Authors:  Franklin G Miller; Howard Brody
Journal:  Hastings Cent Rep       Date:  2003 May-Jun       Impact factor: 2.683

6.  Therapeutic misconception in clinical research: frequency and risk factors.

Authors:  Paul S Appelbaum; Charles W Lidz; Thomas Grisso
Journal:  IRB       Date:  2004 Mar-Apr

Review 7.  Interventions to improve research participants' understanding in informed consent for research: a systematic review.

Authors:  James Flory; Ezekiel Emanuel
Journal:  JAMA       Date:  2004-10-06       Impact factor: 56.272

8.  Payment of clinical research subjects.

Authors:  Christine Grady
Journal:  J Clin Invest       Date:  2005-07       Impact factor: 14.808

9.  Study of the media's potential influence on prospective research participants' understanding of and motivations for participation in a high-profile phase I trial.

Authors:  Rebecca D Pentz; Anne L Flamm; Jeremy Sugarman; Marlene Z Cohen; G Daniel Ayers; Roy S Herbst; James L Abbruzzese
Journal:  J Clin Oncol       Date:  2002-09-15       Impact factor: 44.544

10.  Descriptions of benefits and risks in consent forms for phase 1 oncology trials.

Authors:  Sam Horng; Ezekiel J Emanuel; Benjamin Wilfond; Jonathan Rackoff; Karen Martz; Christine Grady
Journal:  N Engl J Med       Date:  2002-12-26       Impact factor: 91.245
View more
  11 in total

1.  When Subjects Violate the Research Covenant: Lessons Learned from a Failed Clinical Trial of Fecal Microbiota Transplantation.

Authors:  Stacy A Kahn; David T Rubin
Journal:  Am J Gastroenterol       Date:  2016-05-10       Impact factor: 10.864

2.  Abortion decisions as inclusion and exclusion criteria in research involving pregnant women and fetuses.

Authors:  Carson Strong
Journal:  J Med Ethics       Date:  2011-06-17       Impact factor: 2.903

Review 3.  The complexity of consenting to clinical research in phase I pediatric cancer studies.

Authors:  Tal Schechter; Ronald Grant
Journal:  Paediatr Drugs       Date:  2015-02       Impact factor: 3.022

4.  Consent and community engagement in diverse research contexts.

Authors: 
Journal:  J Empir Res Hum Res Ethics       Date:  2013-10       Impact factor: 1.742

5.  Performing nondiagnostic research biopsies in irradiated tissue: a review of scientific, clinical, and ethical considerations.

Authors:  Aaron P Brown; David S Wendler; Kevin A Camphausen; Franklin G Miller; Deborah Citrin
Journal:  J Clin Oncol       Date:  2008-08-20       Impact factor: 44.544

6.  A Systematic Review of Pediatric Phase I Trials in Oncology: Toxicity and Outcomes in the Era of Targeted Therapies.

Authors:  Julia W Cohen; Srivandana Akshintala; Eli Kane; Helen Gnanapragasam; Brigitte C Widemann; Seth M Steinberg; Nirali N Shah
Journal:  Oncologist       Date:  2020-01-14

7.  Patient Perceptions in a Nonblinded Randomized Trial of Radiation Therapy Technologies: A Novel Survey Study Exploring Therapeutic Misconception.

Authors:  Dean A Shumway; Amy Motomura; Kent A Griffith; James A Hayman; Lori J Pierce; Reshma Jagsi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-05-23       Impact factor: 7.038

8.  Communication about the risks and benefits of phase I pediatric oncology trials.

Authors:  Rebecca A Hazen; Stephen Zyzanski; Justin N Baker; Dennis Drotar; Eric Kodish
Journal:  Contemp Clin Trials       Date:  2015-01-29       Impact factor: 2.226

9.  How do parents experience being asked to enter a child in a randomised controlled trial?

Authors:  Valerie Shilling; Bridget Young
Journal:  BMC Med Ethics       Date:  2009-02-16       Impact factor: 2.652

10.  Therapeutic Misconception in Psychiatry Research: A Systematic Review.

Authors:  Ivan Sk Thong; Meng Yee Foo; Min Yi Sum; Benjamin Capps; Tih-Shih Lee; Calvin Ho; Kang Sim
Journal:  Clin Psychopharmacol Neurosci       Date:  2016-02-29       Impact factor: 2.582
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.